Rotator cuff injury is a commonly encountered problem within the United States. In most
cases, surgical repair can reduce pain and restore baseline functional status. However,
in the case of an irreparable rotator cuff tear, management becomes more challenging as
these injuries tend to be larger in size, are inelastic secondary to tendon retraction,
and exhibit fatty infiltration and rotator cuff atrophy1. A multitude of surgical
approaches for an irreparable rotator cuff tear have been described in the literature,
including partial repair alone, partial repair with superior capsular reconstruction
(SCR), arthroscopic debridement, graft interposition, balloon spacer arthroplasty, tendon
transfers, and reverse total shoulder arthroplasty (rTSA)2. In younger patients, the
traditional approach to managing these injuries involved partial rotator cuff repair with
subacromial decompression and debridement with the hopes of providing the patient with
some restoration of function and pain relief3,4. Clinical studies have demonstrated that
partial repair can lead to an improvement in pain and function in the early
post-operative period; long-term outcomes following this procedure were less reliable3.
In addition, a high rate of failure has been associated with partial rotator cuff repair
alone. Partial repair with SCR is a relatively new surgical procedure that has become an
increasingly popular treatment modality in recent years because of early promising
biomechanical and functional outcomes5,6. However, there have been no prospective
randomized assessments of SCR. Therefore, the long-term outcomes of SCR compared to the
standard of care, namely partial rotator cuff repair, are unknown.
This will be a multi-center, prospective randomized controlled trial. Prior to
enrollment, patients will be screened for inclusion criteria. Participants who meet the
eligibility criteria and are suspected to have an irreparable rotator cuff tear will be
randomized into one of the two treatment arms prior to surgery. Group 1 will receive
partial rotator cuff repair alone while group 2 will receive partial rotator cuff repair
with SCR. All patients with suspected irreparable rotator cuff tears will be consented in
clinic. There is the potential situation where the surgeon believed that the rotator cuff
tear was irreparable based on clinical and radiographic evidence but was able to
completely repair the tear intraoperatively. Based on the modified intention-to-treat
(mITT) principle, these select patients will be dropped from the study and will no longer
be followed for research purposes. Randomization will occur with a stratified
randomization excel spreadsheet. Each group will be followed post-operatively for 24
months. The primary objective of this study is to compare pain and functional outcomes
between the two treatment arms. The secondary objective is to assess the failure rate
between the two treatment arms.
All patients with a strongly suspected irreparable rotator cuff tear will be
identified in the clinics of the treating physicians and be screened for inclusion
and exclusion criteria. The consent form will be reviewed in depth with the patients
by an IRB-approved member of the study team, and all questions will be answered
prior to enrollment in the study. Patients will be asked if they need additional
time to review the consent, and no coercion will occur throughout the consent
process. Although patients will be consented at this clinic visit, they will be
informed that there is a possibility that they will ultimately be excluded from the
study because an irreparable rotator cuff tear can only be confirmed
intraoperatively.
At the initial pre-operative clinic visit, patient demographics will be collected
and the pain and functional status of patients will be assessed using VAS, SST,
ASES, and PROMIS-29 scores. It should take approximately 15 minutes to complete
these surveys in clinic.
Patients requiring medical clearance to ensure their health is optimized for surgery
will do so. After receiving medical clearance (if needed), the patients will undergo
surgery.
Patients will be randomized prior to surgery into one of two possible treatment arms
as described above. Stratified randomization will be performed with Microsoft Excel.
If a patient, who was suspected to have an irreparable rotator cuff tear based on
clinical and radiographic findings, is amenable to a complete rotator cuff tear,
they will be dropped from the study and no longer followed for research purposes.
This is based on the mITT principle.
On the day of surgery, the patient will receive either a partial rotator cuff repair
alone or a partial rotator cuff repair with SCR.
Intraoperative data will be collected. For both groups, the investigators will
assess if the following were performed during the procedure: subacromial
decompression, biceps tenotomy vs. tenodesis, marginal convergence, single vs.
double-row repair, and repair of the subscapularis muscle. For the SCR group, the
size (mm2) and width (mm) of the acellular dermal allograft will be recorded.
Finally, any complications that occur intraoperatively will be recorded for both
groups.
After discharge from the surgery center, both groups of patients will be given
identical pain medication regimens, post-operative restrictions, and clinical
follow-up schedule. They will be instructed to follow-up in clinic at 6 weeks, 3, 6,
12, and 24 months post-operatively.
At each post-operative appointment, the patients will again be administered the VAS,
SST, ASES, and PROMIS-29 questionnaires. Complications will be assessed at each
visit. In addition, at the 12-month follow-up appointment, each patient in both
groups will be given a prescription for an MRI of the operative shoulder to assess
for failure of the repair.
Key variables for analysis will be found within the electronic medical record, and
in questionnaires administered at clinic appointments. They include: age at time of
surgery, sex, height, weight, hand dominance, laterality of surgery, mechanism of
injury, and surgical complications (e.g., infection, failure of repair).